Adolescent
Anti-Bacterial Agents
/ therapeutic use
Community-Acquired Infections
/ drug therapy
Female
Humans
Male
Methicillin
/ therapeutic use
Methicillin-Resistant Staphylococcus aureus
/ drug effects
Microbial Sensitivity Tests
/ methods
Oxazolidinones
/ therapeutic use
Staphylococcal Infections
/ drug therapy
Tetrazoles
/ therapeutic use
United States
CA-MRSA
Sivextro
clindamycin
oxazolidinone
Journal
Microbial drug resistance (Larchmont, N.Y.)
ISSN: 1931-8448
Titre abrégé: Microb Drug Resist
Pays: United States
ID NLM: 9508567
Informations de publication
Date de publication:
Historique:
pubmed:
30
1
2019
medline:
26
12
2019
entrez:
30
1
2019
Statut:
ppublish
Résumé
Tedizolid activity was compared with other agents with oral and intravenous formulations against community-acquired methicillin-resistant
Identifiants
pubmed: 30694735
doi: 10.1089/mdr.2018.0410
doi:
Substances chimiques
Anti-Bacterial Agents
0
Oxazolidinones
0
Tetrazoles
0
tedizolid
97HLQ82NGL
Methicillin
Q91FH1328A
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM